Group One Trading’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,350
| Closed | -$280K | – | 3693 |
|
|
2025
Q1 | $280K | Buy |
25,350
+23,961
| +1,725% | +$265K | ﹤0.01% | 727 |
|
|
2024
Q4 | $14.8K | Sell |
1,389
-6,385
| -82% | -$68K | ﹤0.01% | 1467 |
|
|
2024
Q3 | $98.7K | Sell |
7,774
-1,515
| -16% | -$19.2K | ﹤0.01% | 868 |
|
|
2024
Q2 | $156K | Buy |
+9,289
| New | +$156K | ﹤0.01% | 735 |
|
|
2024
Q1 | – | Sell |
-100
| Closed | -$1.5K | – | 3230 |
|
|
2023
Q4 | $1.5K | Buy |
+100
| New | +$1.5K | ﹤0.01% | 1638 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3368 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3319 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3214 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3259 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3245 |
|
|
2022
Q1 | – | Sell |
-14,036
| Closed | -$133K | – | 3269 |
|
|
2021
Q4 | $133K | Sell |
14,036
-29,592
| -68% | -$280K | ﹤0.01% | 1313 |
|
|
2021
Q3 | $734K | Sell |
43,628
-9,146
| -17% | -$154K | ﹤0.01% | 713 |
|
|
2021
Q2 | $806K | Sell |
52,774
-35,825
| -40% | -$547K | ﹤0.01% | 664 |
|
|
2021
Q1 | $1.73M | Sell |
88,599
-41,142
| -32% | -$801K | ﹤0.01% | 416 |
|
|
2020
Q4 | $2.34M | Sell |
129,741
-25,169
| -16% | -$454K | ﹤0.01% | 299 |
|
|
2020
Q3 | $2.99M | Buy |
154,910
+90,038
| +139% | +$1.74M | 0.01% | 177 |
|
|
2020
Q2 | $1.69M | Buy |
64,872
+42,930
| +196% | +$1.12M | 0.01% | 216 |
|
|
2020
Q1 | $391K | Sell |
21,942
-6,154
| -22% | -$110K | ﹤0.01% | 403 |
|
|
2019
Q4 | $938K | Buy |
+28,096
| New | +$938K | 0.01% | 304 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2018 |
|
|
2018
Q4 | – | Sell |
-180
| Closed | -$9K | – | 2073 |
|
|
2018
Q3 | $9K | Buy |
+180
| New | +$9K | ﹤0.01% | 1207 |
|